Are preoperative acute phase proteins serum levels associated with clinical outcome in non-small cell lung cancer patients?;Czy przedoperacyjne stȩżenie bialłek ostrej fazy we krwi u chorych na niedrobnokomórkowego raka plłuca może korelować z przebiegiem klinicznym choroby?

Kardiochirurgia i Torakochirurgia Polska

Volumn 7, Issue 4, 2010, Pages 415-420

  Kasprzyk, Mariusz ^a   Dyszkiewicz, Wojciech ^a   Roszak, Magdalena ^b   Gabryel, Piotr ^a   Galłȩcki, Bartlłomiej ^a  

^a Klinika Torakochirurgii   (Poland)

^b NONE   (Poland)

Author keywords

Acute phase proteins; Lung cancer; Prognostic factors; Surgical treatment

Indexed keywords

EID: 79951488838     PISSN: 17315530     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80. (Pubitemid 24049800)
2. D'Armiento J, Dalal SS, Chada K. Tissue, temporal and inducible expression pattern of haptoglobin in mice. Gene 1997; 195: 19-27. (Pubitemid 27336956)
3. Kushner I, Mackiewicz A. Acute phase proteins as disease markers. Dis Markers 1987; 5: 1-11. (Pubitemid 17063156)
4. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 1982; 389: 39-48. (Pubitemid 12013176)
5. Grenier A. Dehoux M, Boutten A, Arce-Vicioso M, Durand G. Oncostatin M production and regulation by human polymorphonuclear neutrophils. Blood 1999; 93: 1413-1421. (Pubitemid 29076158)
6. Streetz KL, Wustefeld T, Klein C, Manns MP, Trautwein C. Mediators of inflammation and acute phase response in the liver. Cell Mol Biol 2001; 47: 661-673.
7. Atwell DM, Grichnik KP, Newman MF, Reves JG, McBride WT. Balance of proinflammatory and antiinflammatory cytokines at thoracic cancer operation. Ann Thorac Surg 1998; 66: 1145-1150. (Pubitemid 28518040)
8. Smith DR, Kunkel SL, Burdick MD. Production of IL-10 by human bronchogenic carcinoma. Am J Path 1994; 145: 18-25. (Pubitemid 24217477)
9. Bruno R, Olivares R, Berille J, Chaikin P, Vivier N. Alpha-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. Clin Cancer Res 2003; 9: 1077-1082. (Pubitemid 36323714)
10. De Vita F, Orditura M, Galizia G, Romano C, Roscigno A. Serum Interleukin10 levels as a prognostic factor in advanced non-small cell lung cancer patients. Chest 2000; 117: 365-373. (Pubitemid 30111584)
11. Kaminska J, Kowalska M, Kotowicz B, Fuksiewicz M, Glogowski M, Chechlinska M, Steffen J. Pretreatment serum levels of cytokines and cytokine receptors in patients with non-small cell lung cancer and correlations with clinicopathological features and prognosis. Oncology 2006; 70: 115-125. (Pubitemid 43760337)
12. Yildirim A, Meral M, Kaynar H, Polat H, Ucar E. Relationship between serum levels of some acute-phase proteins and stage of disease and performance status in patients with lung cancer. Med Sci Monit 2007; 13: 195-200.
13. Allin KH, Bojesen SE, Nordestgaard BG. Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 2009; 27: 2217-2224.
14. Chaturvedi AK, Caporaso NE, Katki HA, Wong HL, Chatterjee N, Pine SR, Chanock SJ, Goedert JJ, Engels EA. C-reactive protein and risk of lung cancer. J Clin Oncol 2010; 28: 2719-2726.
15. El-Akawi ZJ, Abu-Awad AM, Sharara AM, Khader Y. The importance of alpha-1 antitripsin (alpha1-AT) and neopterin serum levels in the evaluation of non-small cell lung and prostate cancer patients. Neuro Endocrinol Lett 2010; 31: 113-116.
16. Cremona M, Calabro E, Randi G, De Bortoli M, Mondellini P, Verri C, Sozzi G, Pierotti MA, La Vecchia C, Pastorino U, Bongarzone I. Elevated levels of the acute-phase serum amyloid are associated with heightened lung cancer risk. Cancer 2010; 116: 1326-1335.
17. Khan N, Cromer a, Campa M, Patz EF. Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of non-small cell lung carcinoma. Cancer 2004; 101: 379-384.
18. McKeown DJ, Brown DJ, Kelly A, Wallace AM, McMillan DC. The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small cell lung cancer. Br J Cancer 2004; 91: 1993-1995. (Pubitemid 40128764)
19. Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman J. C-reactive protein levels, variation in the C-reactive protein gene and cancer risk: the Rotterdam Study. J Clin Oncol 2006; 24: 5216-5222. (Pubitemid 46631365)
20. Songur N, Kuru B, Kalkan F, Ozdilekcan C, Cakmak H, Hizel N. Serum interleukin-6 levels correlate with malnutrition and survival in patients with advanced non-small cell lung cancer. Tumori 2004; 90: 196-200. (Pubitemid 38745608)
21. Tas F, Duranyildiz D, Argon A, Oguz H, Camlica H. Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancer. Med Oncol 2005; 22: 353-358. (Pubitemid 43780291)
22. Christou NV, Meakins JL Phagocytic and baktericidal functions of polymorphonuclear neutrophils from anergic surgical patients. Can J Surg 1982; 25: 444-448. (Pubitemid 12055826)
23. Craig SR, Leaver HA, Yap PL, Pugh GC, Walker WS. Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardio Thorac Surg 2001; 20: 455-463. (Pubitemid 32743327)
24. Pollock RE, Lotzova E, Stanford SD. Surgical stress impairs natural killer cell programing of tumour for lysis in patients with sarcomas and other solid tumours. Cancer 1992; 70: 2192-2202.
25. Arias-Diaz J, Vara E, Torres-Melero J. Nitrite/nitrate and cytokine levels in bronchoalveolar lavage fluid of lung cancer patients. Cancer 1994; 74: 1546-1551. (Pubitemid 24302973)
26. Martinet N, Charles T, Vaillant R Characterisation of a tumor necrosis factor-alpha inhibitor activity in cancer patients. Am J Respir Cell Mol Biol 1992; 6: 510-515.
27. Partanen R, Koskinen H, Hemminki K. Tumor necrosis factor-alpha (TNFalpha) in patients who have asbestosis and develop cancer. Occup Environ Med 1995; 52: 316-319.
28. Mahmoud FA, Rivera NI. The role of C-reactive protein as a prognostic indicator in advanced cancer. Curr Oncol Rep 2002; 4: 250-255.
29. Hara M, Matsuzaki Y, Shimuzu T, Tomita M, Ayabe T, Enomoto Y, Onitsuka T. Preoperative serum C-reactive protein level in non-small cell lung cancer. Anticancer Res 2007; 27: 3001-3004. (Pubitemid 47228036)
30. Liu DH, Wang XM, Zhang U. Serum amyloid A protein: a potential biomarker correlated with clinical stage of lung cancer. Biomed Environ Sci 2007; 20: 33-40.
31. Lee JG, Cho BC, Bae MK, Lee CY, Park IK, Kim DJ, Ahn SV, Chung KY. Preoperative C-reactive protein levels are associated with tumor size and lymphovascular invasion in resected non-small cell lung cancer. Lung Cancer 2009; 63: 106-110.
32. Bharti A, Ma PC, Maulik G, Singh R, Khan E, Skarin AT. Haptoglobin alphasubunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer. Anticancer Res 2004; 24: 1031-1038. (Pubitemid 38624933)